A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection

Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients

NCT00000733 ·Status: COMPLETED ·Phase: PHASE1

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

NCT01237444 ·Status: COMPLETED ·Phase: PHASE3

A Study of 1592U89 in HIV-Infected Patients

NCT00002388 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

NCT01700790 ·Status: TERMINATED ·Phase: PHASE4

A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients

NCT00002223 ·Status: COMPLETED ·Phase: NA

A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

NCT00524368 ·Status: COMPLETED ·Phase: PHASE3

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

NCT00234975 ·Status: COMPLETED ·Phase: PHASE4

A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

NCT02289482 ·Status: TERMINATED ·Phase: PHASE1

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

NCT00771498 ·Status: COMPLETED ·Phase: PHASE4

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

NCT00179335 ·Status: COMPLETED

Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

NCT01047995 ·Status: COMPLETED ·Phase: PHASE1

TDM of Generic Lopinavir/Ritonavir 200/50 mg

NCT00802334 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

NCT00420355 ·Status: TERMINATED ·Phase: PHASE4

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

NCT00102986 ·Status: COMPLETED ·Phase: NA

BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects

NCT00388492 ·Status: UNKNOWN

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

NCT00435929 ·Status: COMPLETED ·Phase: PHASE1

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

NCT00027339 ·Status: COMPLETED ·Phase: PHASE2

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

NCT00043966 ·Status: COMPLETED ·Phase: PHASE3

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

NCT00004578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

NCT00920088 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

NCT00234923 ·Status: COMPLETED ·Phase: PHASE3

Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects

NCT02251223 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

NCT02348177 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Low-dose Darunavir in a Switch Study

NCT02671383 ·Status: COMPLETED ·Phase: PHASE3

A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

NCT00002364 ·Status: COMPLETED ·Phase: PHASE2